影响咳嗽变异型哮喘预后的高危因素分析

万敏; 张巧; 傅银; 王长征; 马千里

doi:10.16016/j.1000-5404.201908003

您当前的位置：

首页 >

文章列表页 >

影响咳嗽变异型哮喘预后的高危因素分析

临床医学 | 更新时间：2026-01-09

- 影响咳嗽变异型哮喘预后的高危因素分析
- High risk factors affecting the prognosis of cough variant asthma: analysis of 73 cases
- 第三军医大学学报 2020年42卷第2期页码：176-180
- 作者机构：
  
  400037 重庆，陆军军医大学第二附属医院呼吸与危重症医学中心
- 作者简介：
  
  [马千里，E-mail: cqmql@163.com MA Qianli, E-mail: cqmql@163.com
- 基金信息：
  
  国家科技支撑计划(2013BAI09B09);国家科技支撑计划(2014BAI08B05)
- DOI：10.16016/j.1000-5404.201908003
  中图分类号： R195.4;R441.5;R562.25
- 收稿：2019-08-01，
  
  修回：2019-10-30，
  
  纸质出版：2020-01-30
- 稿件说明：
移动端阅览
万敏, 张巧, 傅银, 等. 影响咳嗽变异型哮喘预后的高危因素分析[J]. 第三军医大学学报, 2020,42(2):176-180.

Min WAN, Qiao ZHANG, Yin FU, et al. High risk factors affecting the prognosis of cough variant asthma: analysis of 73 cases[J]. Journal of Third Military Medical University, 2020, 42(2): 176-180.
万敏, 张巧, 傅银, 等. 影响咳嗽变异型哮喘预后的高危因素分析[J]. 第三军医大学学报, 2020,42(2):176-180. DOI： 10.16016/j.1000-5404.201908003.

Min WAN, Qiao ZHANG, Yin FU, et al. High risk factors affecting the prognosis of cough variant asthma: analysis of 73 cases[J]. Journal of Third Military Medical University, 2020, 42(2): 176-180. DOI： 10.16016/j.1000-5404.201908003.

摘要

目的

探讨影响咳嗽变异型哮喘患者预后的高危因素。

方法

基于慢性咳嗽标准化随访数据库患者数据

筛选随访大于5年，核心医疗信息和预后信息采集完整的，且不合并其他慢性咳嗽病因诊断的咳嗽变异型哮喘患者的数据，按照药物治疗需求情况分为低治疗需求组和高治疗需求组，通过回顾性分析比较两组间不同临床特征的差异，以及各临床特征与结局分组之间的相关性，并进一步采用Logistic回归对各临床特征对结局分组的影响进行分析，采用判别函数分析临床指标对结局的可能预测效果。

结果

共73例符合标准的患者纳入分析，超过一半患者(38例，52.1%)经过短期治疗后，未来5年(中位随访时间)内未再次经历以吸入糖皮质激素为核心的针对性治疗。在低治疗需求组和高治疗需求组之间存在显著差异(

0.05)的临床参数包括:PD20、合并咽喉部体征患者比例和咽喉部体征数；PD20、咽后壁淋巴滤泡增生和充血与结局分组存在显著相关性，前两个被作为高危因素纳入到Logistic回归方程中；通过判别函数分析，采用前述两临床指标正确分组比例为74%。

结论

咳嗽变异型哮喘患者经过短期治疗后，未来无治疗需求患者比例不容低估，咳嗽变异型哮喘患者同时存在过度治疗和治疗不足的风险；而其高危因素是PD20和咽后壁淋巴滤泡增生程度，高PD20，低咽后壁淋巴滤泡增生患者未来治疗需求低。

Abstract

Objective

To explore the high risk factors affecting the prognosis of patients with cough variant asthma (CVA).

Methods

From the standardized follow-up database of patients with chronic cough

we retrieved the data of patients with CVA followed up for more than 5 years with complete clinical and prognostic data. According to the demand of medications

the patients were divided into low- and high-demand treatment groups for comparative analysis of the clinical characteristics and their correlation with the outcomes of the patients. Logistic regression was used to identify the risk factors associated with the prognosis of the patients

and the discriminant function was used to determine the cut-off values of the specific risk factors for predicting the patients' outcomes.

Results

We retrieved the data of 73 eligible patients from the database. Thirty-eight (52.1%) of the patients did not experience any treatment with inhaled corticosteroids (ICS) in 5 years (the median follow-up time) following a short-term treatment. The low- and high-demand treatment groups differed significantly in PD20

number of laryngopharyngeal signs and percentage of patients with laryngopharyngeal signs. PD20 and lymphoid follicle hyperplasia and congestion of the posterior pharyngeal wall showed significant correlations with the outcomes of the patients

and the former two factors were identified as risk factors by the logistic regression model. Discriminant function analysis showed that 74% of the patients were grouped correctly for the outcomes based on these two factors.

Conclusion

A substantial portion of CVA patients do not require further treatment in the next 5 years following a short-term treatment. The CVA patients are exposed to co-existing risks of over-treatment and inadequate treatment

and those with a high PD20 level and a low level of lymphoid follicle hyperplasia in the posterior pharyngeal wall have a low demand of further treatment.

关键词

Keywords

references

中华医学会呼吸病学分会哮喘学组.咳嗽的诊断与治疗指南(2015)[J].中华结核和呼吸杂志, 2016. 39(5): 323-354.

Asthma Group of Respiratory Diseases Branch of Chinese Medical Association. Cough diagnosis and treatment guidelines(2015)[J]. Chin J Tuberc Respir Dis, 2016. 39(5): 323-354.

王志虹, 李勇, 黄铁群, 等.支气管激发试验在慢性咳嗽诊断中的意义[J].中国呼吸与危重监护杂志, 2007, 6(4): 245-248.

WANG Z H, LI Y, HUANG T Q, et al . Diagnostic value of bronchial provocation test in patients with chronic cough[J ] . Chin J Respir Crit Care Med, 2007, 6(4): 245-248.

吕寒静, 邱忠民. 2009年版咳嗽诊治指南的解读[J].临床药物治疗杂志, 2011, 9(6): 6-10.

LYU H J, QIU Z M. Interpretation of the 2009 Guidelines for Cough Diagnosis and Treatment[J]. Clin Med J, 2011, 9(6): 6-10.

KOH Y Y, PARK Y, KIM C K. The importance of maximal airway response to methacholine in the prediction of wheezing development in patients with cough-variant asthma[J]. Allergy, 2002, 57(12): 1165-1170. DOI: 10.1034/j.1398-9995.2002.23602.x.

MATSUMOTO H, NⅡMI A, TAKEMURA M, et al . Prognosis of cough variant asthma: a retrospective analysis[J ] . J Asthma, 2006, 43(2): 131-135. DOI: 10.1080/02770900500498477.

DICPINIGAITIS P V. Chronic cough due to asthma: ACCP evidence-based clinical practice guidelines[J]. Chest, 2006, 129(1 Suppl): 75S-79S. DOI: 10.1378/chest.129.1_suppl.75S.

中华医学会呼吸病学分会哮喘学组.咳嗽的诊断与治疗指南(2009版)[J].中华结核和呼吸杂志, 2009. 32(6): 407-413.

Asthma Group of Respiratory Diseases Branch of Chinese Medical Association. Cough diagnosis and treatment guidelines(2009)[J]. Chin J Tuberc Respir Dis, 2009. 32(6): 407-413.

中华医学会呼吸病学分会哮喘学组, 支气管哮喘防治指南(2016年版)[J].中华结核和呼吸杂志, 2016. 39(9): 675-697.

Asthma Group of Respiratory Diseases Branch of Chinese Medical Association. Bronchial asthma prevention and treatment guidelines(2016)[J]. Chin J Tuberc Respir Dis, 2016. 39(9): 675-697.

中华医学会呼吸病学分会哮喘学组.咳嗽的诊断与治疗指南(草案)[J].中华结核和呼吸杂志, 2005. 28(11): 738-744.

Asthma Group of Respiratory Diseases Branch of Chinese Medical Association. Cough diagnosis and treatment guidelines (draft)[J]. Chin J Tubere Respir Dis, 2005. 28(11): 738-744.

KOH Y Y, JEONG J H, PARK Y, et al . Development of wheezing in patients with cough variant asthma during an increase in airway responsiveness[J ] . Eur Respir J, 1999, 14(2): 302-308. DOI:10.1034/j.1399-3003.1999.14b11.x.

FUJIMURA M, NISHIZAWA Y, NISHITSUJI M, et al . Longitudinal decline in pulmonary function in atopic cough and cough variant asthma[J ] . Clin Exp Allergy, 2003, 33(5): 588-594. DOI: 10.1046/j.1365-2222.2003.01658.x.

KIM C K, KIM J T, KANG H, et al . Sputum eosinophilia in cough-variant asthma as a predictor of the subsequent development of classic asthma[J ] . Clin Exp Allergy, 2003, 33(10): 1409-1414. DOI: 10.1046/j.1365-2222.2003.01788.x.

YOO Y, KOH Y Y, KANG H, et al . Sputum eosinophil counts and eosinophil cationic protein levels in cough-variant asthma and in classic asthma, and their relationships to airway hypersensitivity or maximal airway response to methacholine[J ] . Allergy, 2004, 59(10): 1055-1062. DOI: 10.1111/j.1398-9995.2004.00655.x.

袁洁, 安淑华, 高文杰, 等.哮喘和咳嗽变异性哮喘儿童肺常规通气功能的比较[J].中国当代儿科杂志, 2013, 15(3): 171-174.

YUAN J, AN S H, GAO W J, et al . Comparative analysis of conventional pulmonary function test results in children with asthma or cough variant asthma[J ] . Chin J Contemp Pediatr, 2013, 15(3): 171-174.

TAJIRI T, NⅡMI A, MATSUMOTO H, et al . Prevalence and clinical relevance of allergic rhinitis in patients with classic asthma and cough variant asthma[J ] . Respiration, 2014, 87(3): 211-218. DOI: 10.1159/000355706.

FUJIMURA M, NISHIZAWA Y, NISHITSUJI M, et al . Predictors for typical asthma onset from cough variant asthma[J ] . J Asthma, 2005, 42(2): 107-111.

NAKAJIMA T, NISHIMURA Y, NISHIUMA T, et al . Characteristics of patients with chronic cough who developed classic asthma during the course of cough variant asthma: a longitudinal study[J ] . Respiration, 2005, 72(6): 606-611. DOI:10.1159/000087459.

席寅, 赖克方, 陈如冲, 等.咳嗽变异性哮喘的临床特征及其与典型哮喘的关系[J].中华哮喘杂志(电子版), 2011, 5(3): 150-155.

XI Y, LAI K F, CHEN R C, et al . Clinical characteristics of cough variant asthma and it's relasionship with the classic asthma[J ] . Chin J Asthma Electron Ed, 2011, 5(3): 150-155.

浏览量

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

基于中国人群的雌激素受体表达新分层（低/中/高）可更精准地预测HR⁺/HER2^-早期乳腺癌患者的预后

转录因子TGIF1高表达胃癌的免疫抑制性微环境特征及临床意义分析

核仁磷酸蛋白1突变的分子异质性对急性髓系白血病预后的影响

5因子改良衰弱指数联合控制营养状态评分与不可切除肝癌患者介入治疗后总生存期的相关性分析

全身炎症反应指数联合临床病理参数预测宫颈癌复发的模型建立与验证